Cannabis production, while not analogous to synthetic routes used by pharmaceutical companies, still requires testing of the final product. Patients, especially those with suppressed immunity, need to know about their medicine's potency, therapeutic efficacy, and any possible negative components. At Fidelity Diagnostics laboratory, we strive to provide high quality data to providers. We use established quality assurance protocols, validated industry methods, and high complexity instruments; thus assuring that providers have everything they need to inform their patients of therapeutic properties and product safety.
What makes cannabis medicine?
Medical cannabis, or medical marijuana, refers to the use of cannabis and its cannabinoids to treat disease or improve symptoms. Cannabis is an annual plant, originally from Central Asia, which has been used for medicinal purposes throughout history. The biologically active compounds found in the plant are called cannabinoids; at least 66 have been identified so far. Cannabinoids interact with two types of receptors; CB1 receptors which are found predominantly on cells in the brain and spinal cord, and CB2 which are found in various immune cells. Delta-9-tetrahydrocannabinol (THC) is thought to be the most potent cannabinoid. It is believed that cannabinoids may be useful in treating a variety of ailments, namely pain, nausea, muscle spasms, loss of appetite and glaucoma. Cannabis therapeutic properties are also being investigated for cancer patients as a way to alleviate the side effects of cancer therapy. A number of university laboratories are also investigating antitumor properties.
Due to cannabis' unique legal status and the way it is distributed to patients, issues of quality control and safety regulation remain to be fully established. Fidelity Diagnostics is actively pursuing industry transparency from providers and testing facilities; thus promoting the highest level of product integrity.